Literature DB >> 21337361

A modified self-controlled case series method to examine association between multidose vaccinations and death.

Ronny Kuhnert1, Hartmut Hecker, Christina Poethko-Müller, Martin Schlaud, Mechtild Vennemann, Heather J Whitaker, C Paddy Farrington.   

Abstract

The self-controlled case series method (SCCS) was developed to analyze the association between a time-varying exposure and an outcome event. We consider penta- or hexavalent vaccination as the exposure and unexplained sudden unexpected death (uSUD) as the event. The special situation of multiple exposures and a terminal event requires adaptation of the standard SCCS method. This paper proposes a new adaptation, in which observation periods are truncated according to the vaccination schedule. The new method exploits known minimum spacings between successive vaccine doses. Its advantage is that it is very much simpler to apply than the method for censored, perturbed or curtailed post-event exposures recently introduced. This paper presents a comparison of these two SCCS methods by simulation studies and an application to a real data set. In the simulation studies, the age distribution and the assumed vaccination schedule were based on real data. Only small differences between the two SCCS methods were observed, although 50 per cent of cases could not be included in the analysis with the SCCS method with truncated observation periods. By means of a study including 300 uSUD, a 16-fold risk increase after the 4th dose could be detected with a power of at least 90 per cent. A general 2-fold risk increase after vaccination could be detected with a power of 80 per cent. Reanalysis of data from cases of the German case-control study on sudden infant death (GeSID) resulted in slightly higher point estimates using the SCCS methods than the odds ratio obtained by the case-control analysis.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21337361     DOI: 10.1002/sim.4120

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  The emerging landscape of health research based on biobanks linked to electronic health records: Existing resources, statistical challenges, and potential opportunities.

Authors:  Lauren J Beesley; Maxwell Salvatore; Lars G Fritsche; Anita Pandit; Arvind Rao; Chad Brummett; Cristen J Willer; Lynda D Lisabeth; Bhramar Mukherjee
Journal:  Stat Med       Date:  2019-12-20       Impact factor: 2.373

Review 2.  Case-only designs in pharmacoepidemiology: a systematic review.

Authors:  Sandra Nordmann; Lucie Biard; Philippe Ravaud; Marina Esposito-Farèse; Florence Tubach
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

3.  Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990-2010.

Authors:  G S Goldman; N Z Miller
Journal:  Hum Exp Toxicol       Date:  2012-04-24       Impact factor: 2.903

Review 4.  Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review.

Authors:  Nathalie Gault; Johann Castañeda-Sanabria; Yann De Rycke; Sylvie Guillo; Stéphanie Foulon; Florence Tubach
Journal:  BMC Med Res Methodol       Date:  2017-02-08       Impact factor: 4.615

5.  Vaccines and sudden infant death: An analysis of the VAERS database 1990-2019 and review of the medical literature.

Authors:  Neil Z Miller
Journal:  Toxicol Rep       Date:  2021-06-24

Review 6.  Medication safety research by observational study design.

Authors:  Kim S J Lao; Celine S L Chui; Kenneth K C Man; Wallis C Y Lau; Esther W Chan; Ian C K Wong
Journal:  Int J Clin Pharm       Date:  2016-03-22

Review 7.  Pharmacoepidemiological safety studies in children: a systematic review.

Authors:  Osemeke U Osokogu; Julijana Dukanovic; Carmen Ferrajolo; Caitlin Dodd; Alexandra C Pacurariu; Wichor M Bramer; Geert 'tJong; Daniel Weibel; Miriam C J M Sturkenboom; Florentia Kaguelidou
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-06-03       Impact factor: 2.890

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.